Security key
74039M309
- Security type / class
- Equity / COM
- Total 13F shares
- 367,110
- Total 13F value
- $1,208,179
- Share change
- -1,582
- SEC-reported price per share
- $3.29
- Number of holders
- 16
- Value change
- -$4,168
- Number of buys
- 7
- Number of sells
- 5
Report period
Q4 2023
Institutions
16
Top holders
10
POAI full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Axe Compute Inc. SEC filings
Axe Compute Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74039M309
Recent filing periods:
Ownership snapshot
Top reported holders of POAI - Predictive Oncology Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
J. Melville Engle
Disclosed value leader
J. Melville Engle
Comparable rows
0/15
Latest evidence
30 Sep 2023
3/4/5
13F
Highest disclosed value: $1,233,411
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
J. Melville Engle has the largest disclosed position value at $1.23M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens J. Melville Engle's linked filing trail.
Disclosed position value
Top 5
J. Melville Engle
$1.23M
VANGUARD GROUP INC
$449.9K
RAYMOND JAMES & ASSOCIATES
$378.3K
David Stewart Smith
$322.7K
Christina L. Jenkins MD
$213.1K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| J. Melville Engle |
3/4/5
FORMER CEO AND FORMER DIRECTOR
|
—
class O/S missing
|
$1,233,411
416,693 shares
|
— | 01 Nov 2022 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$449,933
140,604 shares
|
— | 30 Sep 2023 |
| RAYMOND JAMES & ASSOCIATES |
13F
Company
|
—
class O/S missing
|
$378,333
118,229 shares
|
— | 30 Sep 2023 |
| David Stewart Smith |
3/4/5
Director
|
—
class O/S missing
|
$322,717
109,026 shares
|
— | 03 Apr 2023 |
| Christina L. Jenkins MD |
3/4/5
Director
|
—
class O/S missing
|
$213,082
71,987 shares
|
— | 01 Jul 2022 |
| Pamela Bush |
3/4/5
Chief Business Officer
|
—
class O/S missing
|
$140,224
47,373 shares
|
— | 31 Jan 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
16
Shares
367,110
Rows available
16
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2025 Across Filers
Q3 2025 holders
2
Q4 2023 holders
16
Holder diff
14
| Investor | Q3 2025 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend